Subsequent molecular assays further uncovered the oncogenic function of one novel low‐abundance isoform from the AKT1 gene (AKT1‐N1) that contrasted with the known function of AKT1,[56–58] indicating a double‐agent attribute of AKT1 with both oncogenic and tumor‐suppressor functions. This evidence concerns the gene AKT1 and neoplasm.